A5053051305- Public Health in Brazil
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Health, Nursing, Elderly Care
- Healthcare during COVID-19 Pandemic
- Academic Research in Diverse Fields
- Business and Management Studies
- Healthcare Regulation
- Medication Adherence and Compliance
- Pharmaceutical studies and practices
- Biotechnology and Related Fields
- Maternal and Neonatal Healthcare
- Telemedicine and Telehealth Implementation
- Economic Theory and Policy
- Innovation Policy and R&D
- Education during COVID-19 pandemic
- Biosimilars and Bioanalytical Methods
- Brazilian Legal Issues
- Thyroid Cancer Diagnosis and Treatment
- Women's cancer prevention and management
- Housing, Finance, and Neoliberalism
- Patient Satisfaction in Healthcare
- Radiation Dose and Imaging
- Youth, Drugs, and Violence
- Diagnosis and treatment of tuberculosis
Fundação Oswaldo Cruz
2015-2024
Escola Nacional de Saúde Pública
2015-2024
Faculdades Oswaldo Cruz
2021-2022
Secretaria Municipal de Saúde
2010-2020
Universidade do Estado do Rio de Janeiro
2011-2016
This article examines pharmaceutical services and access to essential medicines in Brazil during the 30 years since advent of Brazil's Unified Health System from a comprehensiveness perspective. The following topics are addressed: "realignment" services; human resources concept; rational use medicines; technological advances drug manufacturing; ethical regulation. With strong regulatory focus structural framework centered on National Medicines Policy, past three decades represent mixture...
This study characterized the evolution of Brazilian public telemedicine policy in Unified Health System for 30 years from 1988 to 2019 by analyzing its legal framework. We identified 79 telemedicine-related legislations federal government (laws, decrees, and ordinances) 31 regulations councils health professionals. Three historical phases were established according cycle, material was classified purpose normative documents. The content analysis based on advocacy coalition framework model. Of...
O estudo de abordagem descritiva mapeou obstáculos e estratégias empregadas nas compras públicas equipamentos proteção individual (EPI). Envolveu a aplicação questionário eletrônico autopreenchido profissionais com experiência compras, oriundos hospitais públicos federais, composto por questões sobre características gerais, problemas mais recorrentes usadas frente aos processos aquisitivos sete EPI selecionados (avental, máscara cirúrgica, respiradora PFF2 ou N95, touca, protetor facial,...
ResumoO Programa Farmácia Popular do Brasil (PFPB) visa aumentar o acesso a medicamentos, disponibilizando produtos subsidiados. Estrutura-se em arranjos que envolvem os setores público e privado. O trabalho descreveu organização expansão PFPB examinou comportamento dos valores de referência (VR) medicamentos pagos pelo governo, entre 2004-2012. Estudo exploratório, qualiquantitativo, desenvolvido partir pesquisa bibliográfica análise documentos públicos. Dados quantitativos foram levantados...
The National Commission for incorporation of Health Technologies (CONITEC), established in 2011, advises the Ministry decisions related to incorporation, exclusion or change medicines, products and procedures Unified System (SUS).The study investigated decision-making process, profile demands new medicines SUS from January/2012 June/2016, based on data available CONITEC website. All submissions were evaluated characterized by technology applicant type. incorporations analyzed according...
Pharmaceutical services and the formulation of a medicines policy are SUS areas ensured by organic health care law 8,080/90. Thus, after widely participative process, involving stakeholders, National Medicines Policy (NMP) was approved in 1998 Ordinance 3,916.The NMP presents directives priorities, aligned with law, which should guide federal, states municipals entities actions to achieve goals. Considering almost 20 years NMP, this paper took stock discussed some light principles. It not...
Aim: Creation of a single indicator access to medicines. Methods: Data collection was performed with individuals who obtained their medication from either public and/or private pharmacies. A Likert scale used measure the importance and satisfaction in relation various dimensions. Results: total 580 were interviewed. Overall, participants attributed very similar scores dimensions The results mean score each dimension showed statistically significant difference according type pharmacy that...
This article aims to analyze the development of pharmaceutical services in context primary health care (PHC) period 2008- 2014, focusing on selection, procurement and financing medicines. A retrospective study was undertaken, using as data sources administrative documents Rio de Janeiro Municipality Health Secretariat (SMS-RJ) well secondary database. We found a growth numbers medicines offered for PHC 57 items 2008 222 2014. Actual spending drugs paid by city has grown 38% period, with...
The provision of medicines in Brazil is marked by the predominance private expenditures and supply pharmacies historically liberal regulation retail drug sales. first two decades 21st century witnessed expansion concentration pharmaceutical sector growing financialization health sector. article analyzes characteristics Brazilian companies, considering following three crosscutting dimensions: ownership structure, financial/accounting, political. Quantitative qualitative data from various...
O trabalho mapeou a aplicação dos recursos financeiros em pesquisa e desenvolvimento saúde (P&D/S) pelo Ministério da Saúde no período 2003-2005, conforme Agenda Nacional de Prioridades Pesquisa (ANPPS), estabelecida 2004. Utilizaram-se dados procedentes realizada com finalidade primária mensurar esses fluxos investimento período. Foi computado apenas o financiamento direto efetivamente pago pesquisas, excluindo-se dispêndios salários. As pesquisas foram categorizadas segundo as 24...
ABSTRACT OBJECTIVE To analyze the costs of public pharmaceutical services compared to Farmácia Popular Program (Popular Pharmacy Program). METHODS Comparison between prices paid by Aqui Tem (Farmácia is available here) with full medicine provision Municipal Health Department Rio de Janeiro. The comparison comprised 25 medicines supplied both municipal service and Program. Calculating cost per unit each included expenditure Janeiro procurement (price), logistics, local dispensation. reference...
Resumo O processo de transição demográfica brasileiro tem levado a substancial envelhecimento populacional e aumento na prevalência síndromes demenciais, entre as quais se destaca Doença Alzheimer (DA). Desde 2002, o tratamento farmacológico da doença possui Protocolo Clínico Diretrizes Terapêuticas (PCDT) específico os medicamentos recomendados são financiamento pelo Ministério Saúde. estudo investigou aquisição dos utilizados no DA partir do Sistema Integrado Administração Serviços Gerais,...
O estudo analisou o comportamento histórico das compras de medicamentos da Secretaria Municipal do Rio Janeiro, Brasil, entre 2002-2011. Utilizaram-se dados financeiros sobre quantidade anual total adquirida e preço unitário. Calcularam-se gasto por habitante a proporção despesas com frente aos gastos municipais em saúde. Os foram ajustados pelo Índice Preços ao Consumidor Amplo para compará-los 2011. classificados, segundo ambiente predomínio uso, hospitalar ou atenção primária pelas...
This paper aims to analyse changes in the retail pharmaceutical market following policy Farmácia Popular Program (FP), a medicines subsidy program Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private pharmacy sales volume (pharmaceutical units) and values 2002 2013. Analyses evaluated share key FP changes. was selected due its relevance hypertension...
Abstract Background Increasing medicines availability and affordability is a key goal of Brazilian health policies. “ Farmácia Popular ” (FP) Program one the government’s strategies to achieve this goal. Under FP, antihypertension (HTN) antiglycemic (DM) have been provided at subsidized prices in private retail settings since 2006, free charge 2011. We aim assess impact sequential changes FP benefits on patient government expenditures for HTN DM treatment under examine their implications...
A tomografia de emissão pósitrons (PET) é uso recente no Brasil e há necessidade se estimar os custos do procedimento, forma a subsidiar estudos avaliação econômica sobre tecnologia. O trabalho analisou o processo produção da PET-TC utilizando 18 F-FDG estimou seus na perspectiva um provedor público serviços saúde. Utilizou- técnica microcustos, com identificação, quantificação valoração todos insumos consumidos procedimento. As estimativas custo consideraram observação 85 exames realizados...
O trabalho examinou os investimentos em pesquisa e desenvolvimento saúde (P&D/S) do Ministério da Saúde (MS) durante 2000-2002, buscando confrontá-los com itens Agenda Nacional de Prioridades Pesquisa Saúde, modo a estabelecer uma linha base que possibilite posteriores avaliações seu papel indutor. Utilizaram-se dados procedentes realizada finalidade primária mensurar recursos investidos P&D/S no país período, sendo considerados apenas oriundos próprio MS. As pesquisas foram...